We are live on
!
Find out more
CCM
Cupps Capital Management Portfolio holdings
AUM
$231M
1-Year Est. Return
49.73%
This Fund
S&P 500
This Quarter
Est. Return
+19.18%
1 Year Est. Return
+49.73%
3 Year Est. Return
+212.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
-$156M
(-40%)
Cap. Flow
-$194M
Cap. Flow
% of AUM
-83.99%
Top 10 Holdings %
Top 10 Hldgs %
24.21%
Holding
206
New
45
Increased
20
Reduced
112
Closed
29
Top Buys
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$2.5M |
| 2 |
Glaukos
GKOS
|
+$2.17M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
+$1.61M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
+$1.52M |
| 5 |
BLUE
bluebird bio
BLUE
|
+$1.51M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$9.12M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
+$8.36M |
| 3 |
Amazon
AMZN
|
+$7.51M |
| 4 |
Burlington
BURL
|
+$6.63M |
| 5 |
Texas Roadhouse
TXRH
|
+$5.36M |
Sector Composition
| 1 | Technology | 39.39% |
| 2 | Healthcare | 24.2% |
| 3 | Consumer Discretionary | 10.03% |
| 4 | Industrials | 9.46% |
| 5 | Real Estate | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
JPMorgan Chase
JPM
$912B
| $47K | 0.02% |
+720
| New | +$46.9K |
|
152
Xencor
XNCR
$1.11B
| $47K | 0.02% |
+1,925
| New | +$40.7K |
|
153
Tactile Systems Technology
TCMD
$663M
| $46K | 0.02% |
+2,500
| New | +$38.4K |
|
|
RP
154
DELISTED
RealPage, Inc.
RP
| $40K | 0.02% |
+1,570
| New | +$39.1K |
|
155
Salesforce
CRM
$141B
| $37K | 0.02% |
525
-57,900
| -99% | -$4.52M |
|
156
Ultragenyx Pharmaceutical
RARE
$2.98B
| $36K | 0.02% |
520
-19,859
| -97% | -$1.27M |
|
|
CELG
157
DELISTED
Celgene Corp
CELG
| $11K | ﹤0.01% |
112
-12,759
| -99% | -$1.38M |
|
158
Adobe
ADBE
$93.5B
| $4K | ﹤0.01% |
39
-12,821
| -100% | -$1.29M |
|
159
Boston Scientific
BSX
$66.3B
| $4K | ﹤0.01% |
187
-71,431
| -100% | -$1.7M |
|
160
American Tower
AMT
$78.7B
| $3K | ﹤0.01% |
32
-6,862
| -100% | -$784K |
|
161
Corning
GLW
$136B
| $3K | ﹤0.01% |
167
-17,141
| -99% | -$382K |
|
162
Home Depot
HD
$347B
| $3K | ﹤0.01% |
28
-3,321
| -99% | -$443K |
|
163
UnitedHealth
UNH
$384B
| $3K | ﹤0.01% |
24
-3,586
| -99% | -$502K |
|
164
Amgen
AMGN
$201B
| $2K | ﹤0.01% |
+12
| New | +$2.03K |
|
165
Aptiv
APTV
$12.5B
| $2K | ﹤0.01% |
31
-1,358
| -98% | -$91.6K |
|
166
Booking.com
BKNG
$143B
| $2K | ﹤0.01% |
50
-3,100
| -98% | -$173K |
|
167
Cisco
CSCO
$432B
| $2K | ﹤0.01% |
83
-32,417
| -100% | -$997K |
|
168
MGM Resorts International
MGM
$12B
| $2K | ﹤0.01% |
112
-56,363
| -100% | -$1.37M |
|
169
Morgan Stanley
MS
$343B
| $2K | ﹤0.01% |
76
-6,993
| -99% | -$209K |
|
170
PayPal
PYPL
$50B
| $2K | ﹤0.01% |
59
-23,473
| -100% | -$902K |
|
|
CXO
171
DELISTED
CONCHO RESOURCES INC.
CXO
| $2K | ﹤0.01% |
16
-4,310
| -100% | -$546K |
|
172
ASML
ASML
$686B
| $1K | ﹤0.01% |
+15
| New | +$1.59K |
|
173
DuPont de Nemours
DD
$18.1B
| $1K | ﹤0.01% |
12
-1,744
| -99% | -$233K |
|
174
Honeywell
HON
$71.7B
| $1K | ﹤0.01% |
16
-3,506
| -100% | -$366K |
|
175
McDonald's
MCD
$194B
| $1K | ﹤0.01% |
9
-7,875
| -100% | -$933K |
|
Similar funds
SA
WIM
EDRE
RIG
VBCP
TI
ZBI
MI
Cupps Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cupps Capital Management held 206 positions worth $231M, down 40% from $387M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cupps Capital Management withdrew a net $194M in Q3 2016, closing 29 positions and reducing 112 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cupps Capital Management opened a new position in Medidata Solutions, Inc. worth $2.63M.
- Cupps Capital Management's largest Q3 2016 buy was Medidata Solutions, Inc.: 47,254 shares worth $2.63M.
- Cupps Capital Management added most to Cavium, Inc. in Q3 2016, an estimated $1.52M increase.
- Cupps Capital Management's biggest Q3 2016 reduction was Abiomed Inc, cutting an estimated $9.12M.
- Cupps Capital Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $3.68M.
- Cupps Capital Management's ten largest holdings make up 24% of its $231M portfolio in Q3 2016.
- Cupps Capital Management opened 45 new positions and closed 29 in Q3 2016.
- Cupps Capital Management's portfolio value fell 40% quarter-over-quarter to $231M.
Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.